title: [Zoledronic acid-based uveitis: a case report and a bibliography review].
abstract: There are several treatment options for postmenopausic patients suffering from ostopenia or osteoporosis; one of them being inhibition of bone resorption using bisphosphonates. The most common side effects of these drugs are of gastrointestinal nature. There are, of course, other side effects that could jeopardize the function and integrity of other organs or systems. A case of a 58-year-old patient presenting zoledronic-acid induced uveitis symptoms is reported. The importance of this paper lies in that this complication is rather exceptional, in particular if associated with the biphosphonate in question.
authors.affiliation: Red Crea. albani@redcrea.com.mx
authors.forename: Mario
authors.initials: M
authors.lastname: Albani-Campanario
authors.forename: Gerardo
authors.initials: G
authors.lastname: Buendía-Díaz
authors.forename: María de Lourdes
authors.initials: Mde L
authors.lastname: Flores-Islas
authors.forename: Carlos
authors.initials: C
authors.lastname: Maquita-Nakano
authors.forename: Josefina
authors.initials: J
authors.lastname: Ochoa-Cervantes
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008875:Middle Aged; D014605:Uveitis / Q000139:chemically induced*; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid